Rx Marketing Spend Does Exceed R&D, AstraZeneca CEO Says
• By The Pink Sheet
Drug companies can no longer argue that they spend more on research & development than on marketing, AstraZeneca CEO Tom McKillop maintained during the Pharmaceutical Leadership Forum Nov. 16 in Washington, D.C
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights